Apoptosis in adriamycin cardiomyopathy and its modulation by probucol

Antioxidants and Redox Signaling

Volumn 3, Issue 1, 2001, Pages 135-145

  Kumar, D ^a   Kirshenbaum, L A ^a   Li, T ^a   Danelisen, I ^a   Singal, P K ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; DOXORUBICIN; PROBUCOL; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARDIOMYOPATHY; CELL LOSS; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG EFFECT; HEART FAILURE; HEART MUSCLE CELL; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALIA;

EID: 0035084276     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/152308601750100641     Document Type: Article

References (49)

1. Free radicals induced by adriamycin-sensitive and adriamycin-resistant cells: A spin-trapping study
2. Myocyte cell death in the diseased heart
3. Nuclear catalyzed antibiotic free radical formation
4. Alterations in fatty acid metabolism in adriamycin cardiomyopathy
5. Early anthracycline cardiotoxicity
6. Oxidative stress as a mediator of apoptosis
7. Apoptosis of hair follicle cells during doxorubicin-induced alopecia in rats
8. Fine structural changes in rat myocardium induced by daunorubicin
9. Direct detection of paramagnetic species in adriamycin perfused rat hearts
10. Effect of anthracycline antibiotics on oxygen radical formation in rat heart
11. Role of the glutathione - Glutathione peroxidase cycle in the cytotoxicity of the anticancer quinones
12. Anthracycline cardiotoxicity
13. Thermal preconditioning protects rat cardiac muscle cells from doxorubicin-induced apoptosis
14. Coronary artery constriction in rats: Necrotic and apoptotic myocyte death
15. Spin-trapping and direct electron spin resonance investigations of the redox metabolism of quinone anti-cancer drugs
16. Te-99m glucaric acid targets the nucleoproteins of acutely necrotic myocardium but cannot target myocardial cell death due to apoptosis
17. The bcl-2 gene product prevents programmed cell death of ventricular myocytes
18. Apoptosis in isolated adult cardiomyocytes exposed to adriamycin
19. A clinicopathologic analysis of adriamycin cardiotoxicity
20. Apoptosis of vascular smooth muscle cells. Protein kinase C and oncoprotein Bcl-2 are involved in regulation of apoptosis in non-transformed rat vascular smooth muscle cells
21. Adriamycin-induced early changes in myocardial antioxidant enzymes and their modulation by probucol
22. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia
23. Expression of Bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction
24. Melatonin, a pineal hormone with antioxidant property, protects against adriamycin cardiomyopathy in rats
25. Adriamycin: The role of lipid peroxidation in cardiac toxicity and tumor response
26. Apoptosis in myocytes in end-stage heart failure
27. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
28. Apoptosis in the failing human heart
29. Electrolyte and morphologic alterations of myocardium in adriamycin-treated rabbits
30. Mechanism of adriamycin cardiotoxicity: Evidence for oxidative stress
31. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death
32. Cyclic bcl-2 gene expression in human uterine endometrium during menstrual cycle
33. Apoptosis in human acute myocardial infarction
34. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure
35. Subcellular effects of adriamycin in the heart: A concise review
36. 2+ granules in a hypertrophied heart exposed to adriamycin
37. Doxorubicin-induced cardiomyopathy
38. Adriamycin cardiomyopathy: Pathophysiology and prevention
39. Direct effects of adriamycin on the rat heart sarcolemma
40. 2+ binding and lipid peroxidation but depresses myocardial function
41. Combination therapy with probucol prevents adriamycin-induced cardiomyopathy
42. Progress and problems in adriamycin-induced cardiomyopathy
43. Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect
44. Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats
45. Free radical production from normal and adriamycin-treated rat cardiac sarcosomes
46. Myocardial adrenergic changes at two stages of heart failure due to adriamycin treatment in rats
47. Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I
48. Refractory heart failure and age-related differences in adriamycin-induced myocardial changes in rats
49. Doxorubicin-induced apoptosis in spontaneously hypertensive rats: Differential effects in heart, kidney and intestine, and inhibition of ICRF-187